Anthem Blue Cross Blue Shield of California prior authorization, page 68

CPT code lookup

Each row is one code from the public prior authorization list. The description is the procedure or service name on that source row. This is not a coverage decision.

Prior authorization codes

Prior authorization codes
CodeDescriptionSource
J3111Romosozumab-aqqg (Evenity)California PPO Prior Authorization List, Pg 181 Original policy
J3241Teprotumumab-trbw (Tepezza)California PPO Prior Authorization List, Pg 181 Original policy
J3245Tildrakizumab-asmn (Ilumya)California PPO Prior Authorization List, Pg 181 Original policy
J3247Secukinumab (Cosentyx)California PPO Prior Authorization List, Pg 181 Original policy
J3285Treprostinil (Remodulin)California PPO Prior Authorization List, Pg 181 Original policy
J3299Triamcinolone acetonide inj susp (Xipere)California PPO Prior Authorization List, Pg 181 Original policy
J3304Traiamcinolone Acetonide (Zilretta)California PPO Prior Authorization List, Pg 181 Original policy
J3316Triptorelin extended release (Triptodur)California PPO Prior Authorization List, Pg 181 Original policy
J3357Ustekinumab (Stelara)California PPO Prior Authorization List, Pg 181 Original policy
J3358Ustekinumab (Stelara)California PPO Prior Authorization List, Pg 181 Original policy
J3380Vedolizumab (Entyvio)California PPO Prior Authorization List, Pg 181 Original policy
J3385Velaglucerase alfa (VPRIV)California PPO Prior Authorization List, Pg 181 Original policy
J3397Vestronidase alfa (Mepsevii)California PPO Prior Authorization List, Pg 181 Original policy
J3401Beremagene geperpavec (Vyjuvek)California PPO Prior Authorization List, Pg 181 Original policy
J3404Zopapogene imadenovec-drba (Papzimeos)California PPO Prior Authorization List, Pg 181 Original policy
J3489Injection, zoledronic acid, 1 mg (Reclast)California PPO Prior Authorization List, Pg 181 Original policy
J7170Emicizumab-kxwh (Hemlibra)California PPO Prior Authorization List, Pg 183 Original policy
J7171ADAMTS13, recombinant-krhn (Adzynma)California PPO Prior Authorization List, Pg 183 Original policy
J7172Marstacimab-hncq (Hympvazi)California PPO Prior Authorization List, Pg 183 Original policy
J7173Concizumab‑mtci (Alhemo)California PPO Prior Authorization List, Pg 183 Original policy
J7174Fitusiran (Qfitlia)California PPO Prior Authorization List, Pg 183 Original policy
J7175Factor X (Coagadex)California PPO Prior Authorization List, Pg 183 Original policy
J7176Fibrinogen, human-chmt) (Fesilty)California PPO Prior Authorization List, Pg 184 Original policy
J7177Human fibrinogen (Fibryga)California PPO Prior Authorization List, Pg 184 Original policy
J7178Fibrinogen concentrate )RiaSTAP)California PPO Prior Authorization List, Pg 184 Original policy
J7179Von Willebrand Factor (Vonvendi)California PPO Prior Authorization List, Pg 184 Original policy
J7180Factor XIII concentrate (human) (Corifact)California PPO Prior Authorization List, Pg 184 Original policy
J7181Coagulation factor XIII A-subunit (recombinant) (Tretten)California PPO Prior Authorization List, Pg 184 Original policy
J7182Factor VIII (antihemophilic factor, recombinant) (Novoeight)California PPO Prior Authorization List, Pg 184 Original policy
J7183Antihemophilic factor VIII (Wilate)California PPO Prior Authorization List, Pg 184 Original policy
J7185Factor VIII (antihemophilic factor, recombinant) (Xyntha, Xyntha Solofuse)California PPO Prior Authorization List, Pg 184 Original policy
J7186Antihemophilic factor VIII (Alphanate)California PPO Prior Authorization List, Pg 184 Original policy
J7187Antihemophilic factor VIII (Humate-P)California PPO Prior Authorization List, Pg 184 Original policy
J7188Antihemophilic Factor VIII (Obizur)California PPO Prior Authorization List, Pg 184 Original policy
J7189Factor VIIa Recombinant (Novoseven RT)California PPO Prior Authorization List, Pg 184 Original policy
J7190(Factor VIII) human plasma-derived (Hemofil M)California PPO Prior Authorization List, Pg 184 Original policy
J7191Antihemophilic Factor VIII (Obizur)California PPO Prior Authorization List, Pg 184 Original policy
J7192Factor VIII (antihemophilic factor, recombinant) (Advate, Kogenate-FS)California PPO Prior Authorization List, Pg 184 Original policy
J7193Coagulation factor IX (human) (AlphaNine SD)California PPO Prior Authorization List, Pg 184 Original policy
J7194Factor IX Complex Human (Profilnine SD)California PPO Prior Authorization List, Pg 184 Original policy
J7195Factor IX Recombinant (Benefix)California PPO Prior Authorization List, Pg 184 Original policy
J7198Anti-inhibitor coagulant complex (FEIBA)California PPO Prior Authorization List, Pg 184 Original policy
J7200Factor IX Recombinant (Rixubis)California PPO Prior Authorization List, Pg 184 Original policy
J7201Factor IX, Fc fusion protein (recombinant) (Alprolix)California PPO Prior Authorization List, Pg 184 Original policy
J7202Factor IX, albumin fusion protein, (recombinant) (Idelvion)California PPO Prior Authorization List, Pg 185 Original policy
J7203Factor IX, (antihemophilic factor, recombinant), glycopegylated (Rebinyn)California PPO Prior Authorization List, Pg 185 Original policy
J7204Factor VIII (antihemophilic factor (recombinant), glycopegylated-exei (Esperoct)California PPO Prior Authorization List, Pg 185 Original policy
J7205Factor VIII Fc fusion protein, (recombinant) (Eloctate)California PPO Prior Authorization List, Pg 185 Original policy
J7207Factor VIII, (anti-hemophilic factor, recombinant), pegylated (Adynovate)California PPO Prior Authorization List, Pg 185 Original policy
J7208Factor VIII, (antihemophilic factor, recombinant), pegylated- aucl ([Jivi)California PPO Prior Authorization List, Pg 185 Original policy

Sources

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.